 CAMBRIDGE, Mass., Sept. 06, 2022 GLOBE NEWSWIRE -- Cerevel Therapeutics, Nasdaq: CERE, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced that members of the management team will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022. Chairperson and Chief Executive Officer Tony Coles, M.D., will participate in a fireside chat at 9:20AM ET. 